Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
involved in the O-acetylation of GD3 ganglioside sialic acid [RGD, Feb 2006].. Additionally we are shipping MFGE8 Kits (54) and MFGE8 Proteins (24) and many more products for this protein.
Showing 10 out of 187 products:
Human Monoclonal MFGE8 Primary Antibody for CyTOF, FACS - ABIN4899815
Jinushi, Nakazaki, Carrasco, Draganov, Souders, Johnson, Mihm, Dranoff: Milk fat globule EGF-8 promotes melanoma progression through coordinated Akt and twist signaling in the tumor microenvironment. in Cancer research 2008
Show all 2 Pubmed References
This study showed for the first time that MFG-E8 expression is impaired in the endometrium of patients with endometriosis and infertility during the window of implantation.
Our findings suggest that both MFGE8 and TGFbeta1 (show TGFB1 Antibodies) are agerelated inflammatory factors and are related to the degree of Atherosclerosis (AS). In conclusion, both MFGE8 and TGFbeta1 (show TGFB1 Antibodies) may serve as potential markers of the severity of AS
Elevated serum MFG-E8 levels may be associated with cerebrovascular diseases or neuropsychiatric systemic lupus erythematosus.
Circulating MFG-E8 levels are dramatically elevated in pregnancy, and are significantly higher in gestational diabetes mellitus than in normal pregnancy.
MFG-E8 could be a potential novel prognostic marker for colorectal cancer (CRC (show CALR Antibodies)) and overexpression of MFG-E8 might be involved in lymph node metastasis and angiogenesis of CRC (show CALR Antibodies).
MFG-E8 levels are elevated in T2D but suppressed by increased adipose tissues, thereby allowing inflammatory factors to rise to high levels. MFG-E8 may serve as a potential biomarker for obesity and T2D in the clinical setting
These findings provide a better understanding of the molecular mechanism underlying colorectal cancer progression and suggest a predictive role for MFG-E8 in colorectal cancer metastasis and prognosis
Levels of MFGE8 were reduced in cirrhotic liver tissue from patients compared with controls.
an efficient purification method for production of non-aggregated, full-length MFG-E8.
Reduced serum milk fat globule-epidermal growth factor (show EGF Antibodies) 8 (MFG-E8) concentrations are associated with an increased risk of microvascular complications in patients with type 2 diabetes.
The vesicular environment provides optimal conditions for presentation and recognition of phosphatidylserine by lactadherin in a simple binding mechanism.
lactophorin C-terminal fragment (LP16) and bovine milk fat globule membrane protein PAS6/7 strongly inhibited the replication of human rotavirus replication
Lactadherin inhibits enzyme complexes of blood coagulation by competing for phospholipid-binding sites.
The number of lactadherin binding sites increased proportionally to the phosphatidylserine content over a range 0-2% and less rapidly for higher phosphatidylserine content
The crystal structure of the bovine lactadherin C2 domain (residues 1 to 158) at 2.4 A, was determined.
angiogenic endothelial cells have phagocytic properties for lactadherin-opsonized large particles and apoptotic cells
study suggests that LPS (show TLR4 Antibodies) represses MFG-E8 expression and disrupts enterocyte migration via a miR (show MLXIP Antibodies)-99b dependent mechanism.
Mesenchymal stem cell-derived MFG-E8 might accelerate diabetic wound healing by promoting angiogenesis, the clearance of apoptotic cells, and the infiltration of M2 macrophages, and by suppressing inflammatory cytokines in wound area.
MFG-E8 localized to the basal lamina of the mammary gland during involution. Basal MFG-E8 localization promoted integrin-dependent suppression of beta-casein (show CSN2 Antibodies) expression.
MFG-E8 reduces neutrophil migration and neutrophil extracellular traps via downregulating surface CXCR2 (show CXCR2 Antibodies) expression in parallel with its role in the phagocytosis of apoptotic neutrophils.
Mechanistically, ligation of alpha8beta1 by the milk protein Mfge8 reduces antral smooth muscle contractile force by preventing RhoA activation through a PTEN-dependent mechanism.
MFG-E8 administration was associated with decreased inflammasome activation in the kidney. Adoptive transfer of MFG-E8-stimulated macrophages reduced activation of inflammasome and tissue damage. The protective role of MFG-E8 in ureteral obstruction kidney injury is mediated through anti-inflammatory macrophage reprogramming which results in decreased inflammasome activation, preventing severe tissue damage.
characterization of the mechanisms by which macrophage derived MFG-E8 regulates wound inflammation; wound macrophage-derived MFG-E8 was recognized as a critical driver of wound angiogenesis
MFG-E8 acts at two levels, by increasing VEGF (show VEGFA Antibodies) and ET-1 (show EDN1 Antibodies) expression in mesenchymal stromal cells (MSC (show MSC Antibodies)) and by enhancing M2 polarization of macrophages, to increase tumor angiogenesis.
MFGE8 is an anti-fibrotic protein in mesenchymal stem cell secretomes that strongly inhibits TGFbeta (show TGFB1 Antibodies) signaling and reduces extracellular matrix deposition and liver fibrosis in mice.
The evidence suggests that lactadherin and the other F4-binding milk proteins, together with other defense components of milk, could play a role in protection of neonatal piglets against ETEC induced diarrhea.
involved in the O-acetylation of GD3 ganglioside sialic acid
milk fat globule-EGF factor 8 protein
, sperm-membrane associated protein P47
, O-acetyl disialoganglioside synthase
, breast epithelial antigen BA46
, sperm associated antigen 10
, sperm surface protein hP47
, PAS-6/PAS-7 glycoprotein
, components 15/16
, sperm surface protein SP47
, EGF/factor VIII
, milk fat globule glycoprotein
, O-acetyl GD3 ganglioside synthase
, O-acetyltransferase Milk fat glolbule membrane protein
, O-acetyltransferase milk fat globule membrane protein
, milk fat globule EGF factor 8 protein
, pP47 protein